journal article·2018-08

Repurposing Cyanine NIR‐I Dyes Accelerates Clinical Translation of Near‐Infrared‐II (NIR‐II) Bioimaging

Shoujun Zhu, Zhubin Hu, Rui Tian, Bryant C. Yung, Qinglai Yang, Su Zhao, Dale O. Kiesewetter, Gang Niu, Haitao Sun, Alexander L. Antaris, Xiaoyuan Chen

Advanced Materials· Volume 30· Issue 34
Publisher page

Abstract

Abstract The significantly reduced tissue autofluorescence and scattering in the NIR‐II region (1000–1700 nm) opens many exciting avenues for detailed investigation of biological processes in vivo. However, the existing NIR‐II fluorescent agents, including many molecular dyes and inorganic nanomaterials, are primarily focused on complicated synthesis routes and unknown immunogenic responses with limited potential for clinical translation. Herein, the >1000 nm tail emission of conventional biocompatible NIR cyanine dyes with emission peaks at 700–900 nm is systematically investigated, and a type of bright dye for NIR‐II imaging with high potential for accelerating clinical translation is identified. The asymmetry of the π domain in the S1 state of NIR cyanine dyes is proven to result in a twisted intramolecular charge‐transfer process and NIR‐II emission, establishing a general rule to guide future NIR‐I/II fluorophore synthesis. The screened NIR dyes are identified to possess a bright emission tail in the NIR‐II region along with high quantum yield, high molar‐extinction coefficient, rapid fecal excretion, and functional groups amenable for bioconjugation. As a result, NIR cyanine dyes can be used for NIR‐II imaging to afford superior contrast and real‐time imaging of several biological models, facilitating the translation of NIR‐II bioimaging to clinical theranostic applications.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratory of Molecular Imaging and Nanomedicine National Institute of Biomedical Imaging and Bioengineering (NIBIB) National Institutes of Health (NIH) Bethesda MD 20892 USA

State Key Laboratory of Precision Spectroscopy School of Physics and Materials Science East China Normal University Shanghai 200062 China

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine School of Public Health Xiamen University Xiamen 361102 China

Nirmidas Biotech Palo Alto CA 94303 USA

Intuitive Surgical Kifer Rd Sunnyvale CA 94086 USA

Funding

National Institute of Biomedical Imaging and Bioengineering · National Institutes of Health

References (54)

Show source-provided references
1. 10.1038/nnano.2009.29410.1038/nnano.2009.294 ↗
2. 10.1038/s41551-016-001010.1038/s41551-016-0010 ↗
3. 10.1073/pnas.101450110810.1073/pnas.1014501108 ↗
4. 10.1038/s41467-017-00917-610.1038/s41467-017-00917-6 ↗
5. 10.1021/nn301218z10.1021/nn301218z ↗
6. 10.1002/anie.20150747310.1002/anie.201507473 ↗
7. 10.1016/j.addr.2013.10.00210.1016/j.addr.2013.10.002 ↗
8. 10.1038/ncomms319910.1038/ncomms3199 ↗
9. 10.1038/ncomms1470210.1038/ncomms14702 ↗
10. 10.1021/am303110x10.1021/am303110x ↗
11. 10.1073/pnas.152117511310.1073/pnas.1521175113 ↗
12. 10.1002/smll.20170329610.1002/smll.201703296 ↗
13. 10.1038/ncomms1274910.1038/ncomms12749 ↗
14. 10.1021/nn400647210.1021/nn4006472 ↗
15. 10.1039/C7SC00251C10.1039/C7SC00251C ↗
16. 10.1021/cm801911n10.1021/cm801911n ↗
17. 10.1038/nmat447610.1038/nmat4476 ↗
18. 10.1002/adma.20160070610.1002/adma.201600706 ↗
19. 10.1039/C6SC01561A10.1039/C6SC01561A ↗
20. 10.1002/adfm.20170099510.1002/adfm.201700995 ↗
21. 10.1002/adma.20160549710.1002/adma.201605497 ↗
22. 10.1002/anie.20170697410.1002/anie.201706974 ↗
23. 10.1002/anie.20180122610.1002/anie.201801226 ↗
24. 10.1038/ncomms1526910.1038/ncomms15269 ↗
25. 10.1245/s10434-009-0594-210.1245/s10434-009-0594-2 ↗
26. 10.1002/anie.20150228710.1002/anie.201502287 ↗
27. 10.1126/scitranslmed.300157710.1126/scitranslmed.3001577 ↗
28. 10.7150/thno.2448710.7150/thno.24487 ↗
29. Li D. · Theranostics · 2018 · 8 · 250
30. Carr J. A. · bioRxiv · 2017 · 100768
31. 10.1371/journal.pone.018756310.1371/journal.pone.0187563 ↗
32. 10.1073/pnas.171891711510.1073/pnas.1718917115 ↗
33. 10.1016/j.biomaterials.2011.06.02410.1016/j.biomaterials.2011.06.024 ↗
34. 10.1038/nrclinonc.2016.21210.1038/nrclinonc.2016.212 ↗
35. 10.1021/acs.molpharmaceut.6b0109110.1021/acs.molpharmaceut.6b01091 ↗
36. 10.1021/ct400997510.1021/ct4009975 ↗
37. 10.1021/acs.jctc.5b0043110.1021/acs.jctc.5b00431 ↗
38. 10.1039/C5TC03933A10.1039/C5TC03933A ↗
39. 10.1038/clpt.2009.23510.1038/clpt.2009.235 ↗
40. 10.7150/thno.2349110.7150/thno.23491 ↗
41. 10.1038/nphoton.2014.16610.1038/nphoton.2014.166 ↗
42. 10.1038/ncomms520610.1038/ncomms5206 ↗
43. 10.1002/adma.20130193810.1002/adma.201301938 ↗
44. 10.1073/pnas.161799011410.1073/pnas.1617990114 ↗
45. 10.1002/adma.20170579910.1002/adma.201705799 ↗
46. 10.7150/thno.989910.7150/thno.9899 ↗
47. 10.1038/s41467-017-00138-x10.1038/s41467-017-00138-x ↗
48. 10.1038/pj.2017.5910.1038/pj.2017.59 ↗
49. 10.1002/adma.20160293910.1002/adma.201602939 ↗
50. 10.1002/adma.20140011110.1002/adma.201400111 ↗
51. 10.1002/adma.20180133110.1002/adma.201801331 ↗
52. 10.1002/adma.20170685610.1002/adma.201706856 ↗
53. 10.1038/nbt.398710.1038/nbt.3987 ↗
54. 10.1038/s41467-018-03505-410.1038/s41467-018-03505-4 ↗